PMH10 COSTS AND EFFECTS OF RISPERDAL CONSTATM IN COMPARISON TO CONVENTIONAL DEPOT AND SHORT-ACTING ATYPICAL FORMULATIONS IN GERMANY
- 31 December 2003
- journal article
- abstracts
- Published by Elsevier in Value in Health
- Vol. 6 (6), 691-692
- https://doi.org/10.1016/s1098-3015(10)61767-6